PERSISTENCE WITH ANTI-OSTEOPOROTIC THERAPY IN PATIENTS WITH RHEUMATIC DISEASE

被引：0
|
作者：
Mizuki, S. [1 ]
Kushimoto, K. [1 ]
Yamasaki, H. [1 ]
Yoshida, K. [1 ]
Oryoji, K. [1 ]
Kamada, K. [1 ]
Yokota, E. [1 ]
机构：
[1] Matsuyama Red Cross Hosp, Ctr Rheumat Dis, Matsuyama, Ehime, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.4191
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0486
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [11] Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry
    María Begoña Coco-Martín
    Luis Leal-Vega
    José Antonio Blázquez-Cabrera
    Amalia Navarro
    María Jesús Moro
    Francisca Arranz-García
    María José Amérigo
    Manuel Sosa-Henríquez
    María Ángeles Vázquez
    María José Montoya
    Manuel Díaz-Curiel
    José Manuel Olmos
    Marta Ruiz-Mambrilla
    José Filgueira-Rubio
    José Luis Pérez-Castrillón
    European Journal of Clinical Pharmacology, 2023, 79 : 1333 - 1339
  • [12] Initiation of anti-osteoporotic medications in patients with recent fractures
    Abrahamsen, B.
    Roerholt, C.
    Eiken, P.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S209 - S210
  • [13] Influence of non-osteoporotic treatments in patients on active anti-osteoporotic therapy: evidence from the OSTEOMED registry
    Coco-Martin, Maria Begona
    Leal-Vega, Luis
    Blazquez-Cabrera, Jose Antonio
    Navarro, Amalia
    Moro, Maria Jesus
    Arranz-Garcia, Francisca
    Amerigo, Maria Jose
    Sosa-Henriquez, Manuel
    Vazquez, Maria Angeles
    Montoya, Maria Jose
    Diaz-Curiel, Manuel
    Olmos, Jose Manuel
    Ruiz-Mambrilla, Marta
    Filgueira-Rubio, Jose
    Perez-Castrillon, Jose Luis
    OSTEOMED Grp
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 79 (10) : 1333 - 1339
  • [14] Adherence to anti-osteoporotic therapies: role and determinants of "spot therapy"
    Tafaro, L.
    Nati, G.
    Leoni, E.
    Baldini, R.
    Cattaruzza, M. S.
    Mei, M.
    Falaschi, P.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 (08) : 2319 - 2323
  • [15] Potential application of anti-osteoporotic therapy to relieve sarcopenia in the elderly
    Li, Yungui
    Li, Xiaobing
    Kong, Zhaorong
    Yin, Bangfang
    Lan, Zonglin
    Li, Hongjian
    ANNALS OF MEDICINE AND SURGERY, 2023, 85 (12): : 6008 - 6012
  • [16] The use of delta-tocotrienol and lovastatin for anti-osteoporotic therapy
    Abdul-Majeed, Saif
    Mohamed, Norazlina
    Soelaiman, Ima-Nirwana
    LIFE SCIENCES, 2015, 125 : 42 - 48
  • [17] Case studies of kyphoplasty and vertebroplasty integrated by anti-osteoporotic therapy
    Corradini, Costantino
    Malagoli, Emiliano
    Verdoia, Cesare
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2011, 23 : 45 - 46
  • [18] Adherence to anti-osteoporotic therapies: role and determinants of “spot therapy”
    L. Tafaro
    G. Nati
    E. Leoni
    R. Baldini
    M. S. Cattaruzza
    M. Mei
    P. Falaschi
    Osteoporosis International, 2013, 24 : 2319 - 2323
  • [19] Anti-Osteoporotic Drug Use and Cardiovascular Risk in Elderly Patients with Previous Heart Disease
    Sorge, Chiara
    Kirchmayer, Ursula
    Agabiti, Nera
    Cascini, Silvia
    Trifiro, Gianluca
    Lapi, Francesco
    Onder, Graziano
    Fusco, Danilo
    Davoli, Marina
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 166 - 167
  • [20] Rates and reasons for lack of persistence with anti-osteoporotic drugs: analysis of the Campania region database
    Iolascon, Giovanni
    Gimigliano, Francesca
    Moretti, Antimo
    Riccio, Ilaria
    Di Gennaro, Massimo
    Illario, Maddalena
    Monetti, Valeria Marina
    Orlando, Valentina
    Menditto, Enrica
    CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2016, 13 (02) : 127 - 130
12345